Biochemical and Biophysical Research Communications, Vol.469, No.2, 216-221, 2016
Evidence for glucagon-like peptide-1 receptor signaling to activate ATP-sensitive potassium channels in pancreatic beta cells
Glucagon-like peptide-1 (GLP-1) is a gut peptide that promotes insulin release from pancreatic beta cells. GLP-1 has been shown to confer glucose-insensitive beta cells with glucose sensitivity by modulation of the activity of the ATP-sensitive potassium (K-ATP) channel. The channel closing effect of GLP-1, interacting with corresponding G-protein-coupled receptors, has been well established; however, to our knowledge, no study has shown whether GLP-1 directly induces activation of beta-cell K-ATP, channels. Here, we aimed to evaluate whether the activation of beta-cell K-ATP channels by GLP-1 exists and affects intracellular Ca2+ levels ([Ca2+](i)). K-ATP, channel activity was measured in isolated rat pancreatic beta cells by whole cell perforated patch-clamp recordings with a diazoxide-containing pipette solution. Changes in [Ca2+](i) and the subcellular localization of K-ATP channels were observed using the calcium-sensitive dye fura-4/AM and anti-Kir6.2 antibodies in INS-1 beta cells, respectively. To eliminate the well-known inhibitory effects of GLP-1 on K-ATP channel activity, channels were fully inhibited by pretreatment with methyl pyruvate and epigallocatechin-3-gallate. In the pretreated beta cells, GLP-1 and exendin-4 promptly activated the channels, reducing [Ca2+](i). The phosphoinositide 3-kinase (PI3K) inhibitor LY294002 blocked the effects of GLP-1 on channel activity. Moreover, phosphatidylinositol-3,4,5-trisphosphate mimicked the effects of GLP-1. These results suggested that beta-cell GLP-1 receptor signaling involved activation of K-ATP channels via a PI3K-dependent pathway. This alternative mechanism of GLP-1 function may act as a negative feedback pathway, modulating the glucose-dependent GLP-1 inhibition on K-ATP channel activity. (C) 2015 Elsevier Inc. All rights reserved.
Keywords:Glucagon-like peptide-1;Phosphoinositide 3-kinase;Pancreatic beta cell;Glucagon-like peptide-1 receptor;ATP-sensitive potassium channel